Search results for "cost"

showing 10 items of 5421 documents

Microcentrifuge or Automated Hematological Analyzer to Assess Hematocrit in Exercise? Effect on Plasma Volume Loss Calculations

2016

The assessment of plasma volume loss (∆PV) induced by exercise can be estimated from changes in hematocrit (Htc) and hemoglobin (Hb), and it is essential when investigating the metabolic or biologic response to exercise of circulating biomarkers. We aimed to ascertain whether the estimation of ∆PV may differ when Hb and Htc are determined by automated hematological analyzer (AHA) versus manual methods. Twenty-five healthy male subjects performed a maximal running incremental exercise. Blood samples were taken before exercise, immediately after exercise, and after a 30-min recovery. Hb and Htc (Htc-AHA) were determined by an AHA. Htc was also determined by microcentrifugation (Htc-M). The ∆P…

AdultMalemedicine.medical_specialtySpectrum analyzerSysmexAnalytical chemistryCentrifugationHematocritPlasma volumeIncremental exerciseHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumanshemoconcentrationhealth care economics and organizationsplasma volumeAutomation LaboratoryexerciseBiologic responsemedicine.diagnostic_testChemistryDill and Costill equation030229 sport sciencesMiddle AgedhemoglobinHemoconcentrationDill and Costill equation; Sysmex; exercise; hemoconcentration; hemoglobin; plasma volumeHealthy Volunteersdigestive system diseasesComputer Science ApplicationsMedical Laboratory TechnologyCirculating biomarkersHematocritCardiologyHemoglobinBiomarkers030215 immunologySLAS Technology
researchProduct

Robotic Versus Laparoscopic Gastric Resection for Primary Gastrointestinal Stromal Tumors5 cm: A Size-Matched and Location-Matched Comparison.

2017

This study compared robotic (RR) and laparoscopic resection (LR) for primary gastrointestinal stromal tumors (GISTs) of the stomach >5 cm. Twelve consecutive patients who underwent RR from 2012 to 2015 were matched for tumor size and location with 24 patients who underwent LR from 2000 to 2012. The median tumor size was 7.1 cm (range, 5.5 to 11.5). GISTs were resected by wedge resection (91.7%) or distal gastrectomy. The median RR operative time was longer than that of LR (162.5 vs. 130 min, respectively; P=0.004). Only 1 LR patient required conversion. The time to flatus and hospital stay were similar between groups. Overall, 3 patients developed minor postoperative complications that w…

AdultMalemedicine.medical_specialtyStromal cellGastrointestinal Stromal TumorsOperative TimeBlood Loss Surgical030230 surgeryRobotic gastric resectionRisk Assessment03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRobotic Surgical ProceduresStomach Neoplasmslaparoscopic gastric resectionmedicineHumansLaparoscopic resectionGastric resectionUltrasonography InterventionalAgedAged 80 and overTumor sizebusiness.industryStomachIncidence (epidemiology)Length of StayMiddle AgedSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureTreatment OutcomeSurgery Computer-Assisted030220 oncology & carcinogenesisCosts and Cost AnalysisOperative timeSurgeryFemaleLaparoscopybusinessprimary gastrointestinal stromal tumorGISTWedge resection (lung)Surgical laparoscopy, endoscopypercutaneous techniques
researchProduct

Resource utilization and productivity loss in persons with spina bifida—an observational study of patients in a tertiary urology clinic in Germany.

2014

Background and purpose To investigate resource use and burden associated with spina bifida (SB) in Germany. Methods A questionnaire was used to obtain information on SB-related healthcare resource use and assistive technologies used for the last 1 and 10 years. Individuals with SB were recruited at a tertiary specialist clinic. To participate, persons with SB required the cognitive ability to respond or a caregiver to answer questions on their behalf. They could use personal medical charts or other records to answer. The analyses included assessment of frequency and extent of resource use for both time frames. Results Data on 88 persons with a diagnosis of SB were collected (44% female). Du…

AdultMalemedicine.medical_specialtyTertiary Care CentersCost of IllnessGermanyHealth caremedicineHumansSpinal DysraphismHospital daysbusiness.industrySpina bifidaHealth Servicesmedicine.diseaseSelf-Help DevicesHospitalizationNeurologyPhysical therapyUrology clinicResource useObservational studyFemaleNeurology (clinical)businessHealthcare providersResource utilizationEuropean journal of neurology
researchProduct

Duration of immunosuppressive therapy in autoimmune hepatitis

2001

AdultMalemedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classmedicine.medical_treatmentMEDLINEAutoimmune hepatitisGastroenterologyRemission inductionRecurrenceInternal medicinemedicineHumansChildAgedAutoimmune diseaseHepatitisChemotherapyHepatologybusiness.industryRemission InductionMiddle Agedmedicine.diseaseHepatitis AutoimmuneImmunologyCorticosteroidFemalebusinessImmunosuppressive AgentsJournal of Hepatology
researchProduct

Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria

2019

Objectives: Treatment of chronic spontaneous urticaria (CSU) is based on evidence-based guidelines. However, specific patient needs and benefits from therapy have not been differentiated on the guideline level. The current study was designed to use the first part of the PBI, the PNQ, to characterize[for full text, please go to the a.m. URL]

AdultMalemedicine.medical_specialtyTime FactorsCross-sectional studyHealth StatusDermatologyDiseasePatient Care Planning030207 dermatology & venereal diseases03 medical and health sciencesSex Factors0302 clinical medicineCost of IllnessQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansChronic UrticariaDisease burdenChronic urticariaAgedbusiness.industryPruritusPatient PreferenceGuidelineMiddle Aged610 Medical sciences; MedicineCross-Sectional StudiesPatient burden030228 respiratory systemddc: 610Quality of LifeItchingFemalemedicine.symptombusinessDecision Making SharedNeeds Assessment
researchProduct

Differences in contractile behaviour between the soleus and medial gastrocnemius muscles during human walking

2012

The functional roles of individual lower limb muscles during human walking may differ depending on walking speed or duration. In this study, 11 volunteers walked on a treadmill for 60 min at speeds corresponding to both optimal and 20% above optimal energetic cost of transport whilst oxygen consumption and medial gastrocnemius (MG) and soleus fascicle lengths were measured. Although energetic cost of transport was ∼12% higher at the faster speed, it remained constant over 60 min at both speeds, suggesting that humans can walk for prolonged periods at a range of speeds without compromising energetic efficiency. The fascicles of both muscles exhibited rather ‘isometric’ behaviour during the e…

AdultMalemedicine.medical_specialtyTime FactorsPhysiologyMovementMedial gastrocnemiusEnergetic costWalkingAquatic ScienceYoung AdultOxygen ConsumptionPhysical medicine and rehabilitationFunctional importancemedicineHumansTreadmillMuscle SkeletalGaitMolecular BiologyEcology Evolution Behavior and SystematicsStance phaseChemistryAnatomyFascicleRespiratory quotientPreferred walking speedInsect ScienceExercise TestFemaleAnimal Science and Zoologyhuman activitiesMuscle ContractionJournal of Experimental Biology
researchProduct

The costs of social anxiety disorder: The role of symptom severity and comorbidities

2013

Abstract Background Social anxiety disorder (SAD) is associated with low direct costs compared to other anxiety disorders while indirect costs tend to be high. Mental comorbidities have been identified to increase costs, but the role of symptom severity is still vague. The objective of this study was to determine the costs of SAD, and to explore the impact of symptoms and comorbidities on direct and indirect costs. Methods Baseline data, collected within the SOPHO-NET multi-centre treatment study ( N =495), were used. Costs were calculated based on health care utilization and lost productivity. Symptom severity was measured with the Liebowitz-Social-Anxiety-Scale; comorbidities were include…

AdultMalemedicine.medical_specialtyTotal costPopulationComorbidityEfficiencySeverity of Illness IndexYoung Adult03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessAbsenteeismmental disordersHealth caremedicineHumans030212 general & internal medicineSocial BehaviorPsychiatryeducationhealth care economics and organizationseducation.field_of_studybusiness.industrySocial anxietyMiddle Agedmedicine.diseaseAnxiety Disorders3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyEating disordersAbsenteeismAnxietyFemaleSelf Reportmedicine.symptomPsychologybusinessJournal of Affective Disorders
researchProduct

Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.

2019

Background: Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients’ quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced. Objective: To investigate the utility of HIDRAdisk in clinical practice before and after treatment and to analyse whether specific factors such as age and gender may influence the outcomes in patients with moderate-to-severe…

AdultMalemedicine.medical_specialtyVisual Analog ScaleDermatology.Severity of Illness IndexAge and gender030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsDisease severityQuality of lifeHidradenitis suppurativa quality of lifeCost of IllnessInternal medicinemedicineAdalimumabHumansIn patientHidradenitis suppurativa030212 general & internal medicineDisease burdenRetrospective Studiesbusiness.industryAge FactorsRetrospective cohort studyMiddle Agedmedicine.diseaseHidradenitis SuppurativaInfectious DiseasesTreatment OutcomeQuality of LifeFemalebusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEHIDRAdisk outcomesmedicine.drughidradiskJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct

Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients

2019

Objective: Atrial fibrillation (AF) is a major cause for recurrent stroke, has severe impact on a patient's health and imposes a high economic burden for society. Current guidelines recommend 24 h ECG monitoring (standard-of-care, SoC) to detect AF after stroke to reduce the risk of future events. However, paroxysmal AF (PAF) is difficult to detect within this period as it occurs infrequently and unpredictably. In a randomized controlled trial (Find-AF(RANDOMISED)), prolonged and enhanced Holter ECG monitoring (EPM) revealed a significantly higher detection rate of AF compared to SoC, although its cost-effectiveness has not yet been investigated. Methods: Based on the data of FIND-AF(RANDOM…

AdultMalemedicine.medical_specialtymacromolecular substancesCOST-EFFECTIVENESS ANALYSIS030204 cardiovascular system & hematologyGUIDELINESTHERAPYBrain Ischemia03 medical and health sciences0302 clinical medicineRecurrent strokeInternal medicinemedicineMANAGEMENTHumanscardiovascular diseases030212 general & internal medicinequality-adjusted life yearsAcute ischemic strokeStrokeAgedAged 80 and overbusiness.industrycost-benefit analysisAtrial fibrillationGeneral MedicineCost-effectiveness analysisMiddle AgedWirtschaftswissenschaftenmedicine.diseaseAtrial fibrillationstroke3. Good healthQuality-adjusted life yearTRIALSEconomic evaluationATRIAL-FIBRILLATIONCardiologyElectrocardiography AmbulatoryQuality of LifeFemalebusinessHolter monitoringsecondary preventionTASK-FORCE
researchProduct

Ciamexone in endocrine orbitopathy. A randomized double-blind, placebo-controlled study.

1990

Abstract The influence of ciamexone on the activity and course of endocrine orbitopathy was investigated. Fifty-one patients with active orbitopathy classes II-VI were allocated randomly to two groups: over a period of six months, 26 patients received 300 mg/day ciamexone and 25 patients received placebo tablets. In both groups, prednisolone was administered in addition in the first four weeks. Ophthalmological investigations and clinical tests as well as orbit sonography were carried out before as well as one, three and six months after the beginning of therapy. Before and after treatment, computer tomography of the orbit was performed. Symptoms and signs did not show any significant impro…

AdultMalemedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEye diseasePrednisoloneAziridinesPlacebo-controlled studyVisual AcuityPlaceboRandom AllocationEndocrinologyAdjuvants ImmunologicDouble-Blind MethodInternal medicineOrbital DiseasesMedicineHumansExophthalmusIntraocular PressureAgedChemotherapybiologybusiness.industryThyroiditis AutoimmuneEndocrine orbitopathyGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseEndocrinologyPrednisoloneCorticosteroidFemalebusinessmedicine.drugActa endocrinologica
researchProduct